{
    "eid": "2-s2.0-85136343240",
    "title": "Short-term immune response after inactivated SARS-CoV-2 (CoronaVac\u00ae, Sinovac) and ChAdOx1 nCoV-19 (Vaxzevria\u00ae, Oxford-AstraZeneca) vaccinations in health care workers",
    "cover-date": "2022-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "Anti-SARS-CoV-2 total antibody",
        "COVID-19 vaccine",
        "Health care workers",
        "Inactivated SARS-CoV-2 vaccine",
        "SARS-CoV-2 vaccine",
        "Surrogate viral neutralizing antibody titer"
    ],
    "authors": [
        "Watsamon Jantarabenjakul",
        "Napaporn Chantasrisawad",
        "Thanyawee Puthanakit",
        "Supaporn Wacharapluesadee",
        "Nattiya Hirankarn",
        "Vichaya Ruenjaiman",
        "Leilani Paitoonpong",
        "Gompol Suwanpimolkul",
        "Pattama Torvorapanit",
        "Rakchanok Pradit",
        "Jiratchaya Sophonphan",
        "Opass Putcharoen"
    ],
    "citedby-count": 19,
    "ref-count": 23,
    "ref-list": [
        "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial",
        "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial",
        "Immunological mechanisms of vaccine-induced protection against COVID-19 in humans",
        "COVID-19 reinfection: a rapid systematic review of case reports and case series",
        "Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers",
        "Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants",
        "Effectiveness of COvid-19 vaccines against the B.1.617.2 (delta) variant",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction",
        "Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection",
        "Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers",
        "Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival",
        "Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile",
        "Inactivated COVID-19 vaccines to make a global impact",
        "Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial",
        "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",
        "Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants",
        "Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)",
        "Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data",
        "Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study",
        "T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial",
        "Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60031780",
            "affilname": "Thai Red Cross Agency",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031780",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "King Chulalongkorn Memorial Hospital Fund",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}